assembly Bill A169

2021-2022 Legislative Session

Relates to the definition of a serious condition regarding the medical use of marihuana

download bill text pdf

Sponsored By

Current Bill Status - Stricken


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (6)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Apr 20, 2021 enacting clause stricken
recommitted to health
Feb 11, 2021 advanced to third reading cal.87
Feb 09, 2021 reported
Jan 20, 2021 reported referred to codes
Jan 06, 2021 referred to health

Co-Sponsors

view additional co-sponsors

Multi-Sponsors

A169 (ACTIVE) - Details

See Senate Version of this Bill:
S4646
Current Committee:
Law Section:
Public Health Law
Laws Affected:
Amd §3360, Pub Health L
Versions Introduced in Other Legislative Sessions:
2017-2018: A8904
2019-2020: A1125

A169 (ACTIVE) - Summary

Defines a serious condition regarding the medical use of marihuana as a condition, or symptom or complication of the condition or its treatment, for which, in the practitioner's professional opinion and review of past treatments, the patient is likely to receive therapeutic or palliative benefit from primary or adjunctive treatment with medical use of medical marihuana.

A169 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    169
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                (PREFILED)
 
                              January 6, 2021
                                ___________
 
 Introduced by M. of A. GOTTFRIED, LUPARDO, ABINANTI, DINOWITZ, L. ROSEN-
   THAL,  SIMON,  CAHILL,  BRONSON,  HEVESI,  SEAWRIGHT, WEPRIN, WOERNER,
   SAYEGH, TAYLOR, FERNANDEZ, DARLING -- Multi-Sponsored by -- M.  of  A.
   COOK, DeSTEFANO -- read once and referred to the Committee on Health

 AN  ACT to amend the public health law, in relation to the definition of
   a serious condition regarding the medical use of marihuana
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Subdivision 7 of section 3360 of the public health law, as
 added by chapter 90 of the laws of 2014 and paragraph (a) as amended  by
 chapter 273 of the laws of 2018, is amended to read as follows:
   7. [(a)] "Serious condition" means[:
   (i)  having one of the following severe debilitating or life-threaten-
 ing conditions: cancer, positive status for human immunodeficiency virus
 or acquired immune deficiency syndrome, amyotrophic  lateral  sclerosis,
 Parkinson's disease, multiple sclerosis, damage to the nervous tissue of
 the  spinal  cord  with objective neurological indication of intractable
 spasticity,  epilepsy,   inflammatory   bowel   disease,   neuropathies,
 Huntington's disease, post-traumatic stress disorder, pain that degrades
 health  and  functional capability where the use of medical marihuana is
 an alternative to opioid use, substance use disorder, or as added by the
 commissioner; and
   (ii) any of the following conditions where it is clinically associated
 with, or a complication of, a condition  under  this  paragraph  or  its
 treatment:  cachexia or wasting syndrome; severe or chronic pain; severe
 nausea; seizures; severe or persistent muscle spasms; or such conditions
 as are added by the commissioner.
   (b) No later than eighteen months from  the  effective  date  of  this
 section,  the  commissioner shall determine whether to add the following
 serious conditions: Alzheimer's,  muscular  dystrophy,  dystonia,  post-

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets